Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study
- PMID: 23223351
- PMCID: PMC3609510
- DOI: 10.2337/dc12-1316
Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study
Abstract
Objective: We aimed to identify factors that are independently associated with the metabolic clearance rate of insulin (MCRI) and to examine the association of MCRI with incident type 2 diabetes in nondiabetic Hispanics and African Americans.
Research design and methods: We investigated 1,116 participants in the Insulin Resistance Atherosclerosis Study (IRAS) Family Study with baseline examinations from 2000 to 2002 and follow-up examinations from 2005 to 2006. Insulin sensitivity (S(I)), acute insulin response (AIR), and MCRI were determined at baseline from frequently sampled intravenous glucose tolerance tests. MCRI was calculated as the ratio of the insulin dose over the incremental area under the curve of insulin. Incident diabetes was defined as fasting glucose ≥126 mg/dL or antidiabetic medication use by self-report.
Results: We observed that S(I) and HDL cholesterol were independent positive correlates of MCRI, whereas fasting insulin, fasting glucose, subcutaneous adipose tissue, visceral adipose tissue, and AIR were independent negative correlates (all P < 0.05) at baseline. After 5 years of follow-up, 71 (6.4%) participants developed type 2 diabetes. Lower MCRI was associated with a higher risk of incident diabetes after adjusting for demographics, lifestyle factors, HDL cholesterol, indexes of obesity and adiposity, and insulin secretion (odds ratio 2.01 [95% CI 1.30-3.10], P = 0.0064, per one-SD decrease in loge-transformed MCRI).
Conclusions: Our data showed that lower MCRI predicts the incidence of type 2 diabetes.
Figures

References
-
- Duckworth WC, Bennett RG, Hamel FG. The significance of intracellular insulin to insulin action. J Investig Med 1997;45:20–27 - PubMed
-
- Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 1998;19:608–624 - PubMed
-
- Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983;32:438–446 - PubMed
-
- Meistas MT, Margolis S, Kowarski AA. Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol 1983;245:E155–E159 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL061210/HL/NHLBI NIH HHS/United States
- HL-61210-02/HL/NHLBI NIH HHS/United States
- HL-60894/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 DK029867/DK/NIDDK NIH HHS/United States
- DK-079888/DK/NIDDK NIH HHS/United States
- R01 DK079888/DK/NIDDK NIH HHS/United States
- K23 DK065978/DK/NIDDK NIH HHS/United States
- HL-60931-02/HL/NHLBI NIH HHS/United States
- R01 HL060944/HL/NHLBI NIH HHS/United States
- HL-60944-02/HL/NHLBI NIH HHS/United States
- R01 HL061019/HL/NHLBI NIH HHS/United States
- R37 DK027619/DK/NIDDK NIH HHS/United States
- HL-61019-02/HL/NHLBI NIH HHS/United States
- R01 HL060894/HL/NHLBI NIH HHS/United States